{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:23:43Z","timestamp":1793831023330,"version":"4.6.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["H I14C1135"],"award-info":[{"award-number":["H I14C1135"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2C4002366"],"award-info":[{"award-number":["2020R1A2C4002366"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>TAR DNA-binding protein 43 (TDP-43) is a highly conserved nuclear RNA\/DNA-binding protein involved in the regulation of RNA processing. The accumulation of TDP-43 aggregates in the central nervous system is a common feature of many neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer\u2019s disease (AD), and limbic predominant age-related TDP-43 encephalopathy (LATE). Accumulating evidence suggests that prion-like spreading of aberrant protein aggregates composed of tau, amyloid-\u03b2, and \u03b1-synuclein is involved in the progression of neurodegenerative diseases such as AD and PD. Similar to those of prion-like proteins, pathological aggregates of TDP-43 can be transferred from cell-to-cell in a seed-dependent and self-templating manner. Here, we review clinical and experimental studies supporting the prion-like spreading of misfolded TDP-43 and discuss the molecular mechanisms underlying the propagation of these pathological aggregated proteins. The idea that misfolded TDP-43 spreads in a prion-like manner between cells may guide novel therapeutic strategies for TDP-43-associated neurodegenerative diseases.<\/jats:p>","DOI":"10.1038\/s12276-020-00513-7","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T06:05:00Z","timestamp":1602569100000},"page":"1652-1662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":421,"title":["The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies"],"prefix":"10.1038","volume":"52","author":[{"given":"Myungjin","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinrye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mi","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghwi","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"513_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng, C., Trojanowski, J. Q. & Lee, V. M. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 16, 199\u2013212 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"513_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker, M. & Walker, L. C. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat. Neurosci. 21, 1341\u20131349 (2018).","journal-title":"Nat. Neurosci."},{"key":"513_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A. & Higgins, G. A. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256, 184\u2013185 (1992).","journal-title":"Science"},{"key":"513_CR4","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari, S., Atluri, V., Kaushik, A., Yndart, A. & Nair, M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int. J. Nanomed. 14, 5541\u20135554 (2019).","journal-title":"Int. J. Nanomed."},{"key":"513_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","volume":"1739","author":"K Iqbal","year":"2005","unstructured":"Iqbal, K. et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 1739, 198\u2013210 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"513_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik, A., Stewart, T. & Zhang, J. Alpha-synuclein as a biomarker for Parkinson\u2019s disease. Brain Pathol. 26, 410\u2013418 (2016).","journal-title":"Brain Pathol."},{"key":"513_CR7","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis, L. alpha-Synuclein in Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med 2, a009399 (2012).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"513_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mcn.2018.10.003","volume":"97","author":"P Steinacker","year":"2019","unstructured":"Steinacker, P., Barschke, P. & Otto, M. Biomarkers for diseases with TDP-43 pathology. Mol. Cell. Neurosci. 97, 43\u201359 (2019).","journal-title":"Mol. Cell. Neurosci."},{"key":"513_CR9","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"513_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fnmol.2020.00026","volume":"13","author":"W Huang","year":"2020","unstructured":"Huang, W. et al. TDP-43: from Alzheimer\u2019s disease to limbic-predominant age-related TDP-43 encephalopathy. Front. Mol. Neurosci. 13, 26 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"513_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0955-0674(97)80016-6","volume":"9","author":"S Nakielny","year":"1997","unstructured":"Nakielny, S. & Dreyfuss, G. Nuclear export of proteins and RNAs. Curr. Opin. Cell Biol. 9, 420\u2013429 (1997).","journal-title":"Curr. Opin. Cell Biol."},{"key":"513_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s13311-015-0351-0","volume":"12","author":"EL Scotter","year":"2015","unstructured":"Scotter, E. L., Chen, H. J. & Shaw, C. E. Erratum to: TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics 12, 515\u2013518 (2015).","journal-title":"Neurotherapeutics"},{"key":"513_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","volume":"135","author":"T Geuens","year":"2016","unstructured":"Geuens, T., Bouhy, D. & Timmerman, V. The hnRNP family: insights into their role in health and disease. Hum. Genet. 135, 851\u2013867 (2016).","journal-title":"Hum. Genet."},{"key":"513_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"513_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602\u2013611 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"513_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa, M. et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60\u201370 (2008).","journal-title":"Ann. Neurol."},{"key":"513_CR17","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.febslet.2008.07.027","volume":"582","author":"Y Inukai","year":"2008","unstructured":"Inukai, Y. et al. Abnormal phosphorylation of Ser409\/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 582, 2899\u20132904 (2008).","journal-title":"FEBS Lett."},{"key":"513_CR18","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0900688106","volume":"106","author":"YJ Zhang","year":"2009","unstructured":"Zhang, Y. J. et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 106, 7607\u20137612 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"513_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider, J. et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74, 20\u201338 (2013).","journal-title":"Ann. Neurol."},{"key":"513_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","volume":"127","author":"J Brettschneider","year":"2014","unstructured":"Brettschneider, J. et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol. 127, 423\u2013439 (2014).","journal-title":"Acta Neuropathol."},{"key":"513_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","volume":"131","author":"KA Josephs","year":"2016","unstructured":"Josephs, K. A. et al. Updated TDP-43 in Alzheimer\u2019s disease staging scheme. Acta Neuropathol. 131, 571\u2013585 (2016).","journal-title":"Acta Neuropathol."},{"key":"513_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ncb1843","volume":"11","author":"BK Patel","year":"2009","unstructured":"Patel, B. K., Gavin-Smyth, J. & Liebman, S. W. The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat. Cell Biol. 11, 344\u2013349 (2009).","journal-title":"Nat. Cell Biol."},{"key":"513_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1534\/genetics.111.137760","volume":"191","author":"SW Liebman","year":"2012","unstructured":"Liebman, S. W. & Chernoff, Y. O. Prions in yeast. Genetics 191, 1041\u20131072 (2012).","journal-title":"Genetics"},{"key":"513_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fnmol.2019.00262","volume":"12","author":"L McAlary","year":"2019","unstructured":"McAlary, L., Plotkin, S. S., Yerbury, J. J. & Cashman, N. R. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 12, 262 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"513_CR25","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann, M. et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781\u20131784 (2006).","journal-title":"Science"},{"key":"513_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera, F. et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909\u2013913 (2009).","journal-title":"Nat. Cell Biol."},{"key":"513_CR27","doi-asserted-by":"publisher","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","volume":"285","author":"T Nonaka","year":"2010","unstructured":"Nonaka, T., Watanabe, S. T., Iwatsubo, T. & Hasegawa, M. Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J. Biol. Chem. 285, 34885\u201334898 (2010).","journal-title":"J. Biol. Chem."},{"key":"513_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","volume":"330","author":"YS Eisele","year":"2010","unstructured":"Eisele, Y. S. et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330, 980\u2013982 (2010).","journal-title":"Science"},{"key":"513_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"513_CR30","doi-asserted-by":"publisher","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7, e31302 (2012).","journal-title":"PLoS ONE"},{"key":"513_CR31","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"513_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbrc.2012.07.071","volume":"425","author":"CK Chang","year":"2012","unstructured":"Chang, C. K. et al. The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. Biochem. Biophys. Res. Commun. 425, 219\u2013224 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"513_CR33","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/febs.13651","volume":"283","author":"M Mompean","year":"2016","unstructured":"Mompean, M. et al. The TDP-43 N-terminal domain structure at high resolution. FEBS J. 283, 1242\u20131260 (2016).","journal-title":"FEBS J."},{"key":"513_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","volume":"30","author":"SJ Barmada","year":"2010","unstructured":"Barmada, S. J. et al. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 30, 639\u2013649 (2010).","journal-title":"J. Neurosci."},{"key":"513_CR35","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/nar\/gkp013","volume":"37","author":"PH Kuo","year":"2009","unstructured":"Kuo, P. H., Doudeva, L. G., Wang, Y. T., Shen, C. K. & Yuan, H. S. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res. 37, 1799\u20131808 (2009).","journal-title":"Nucleic Acids Res."},{"key":"513_CR36","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/nsmb.2698","volume":"20","author":"PJ Lukavsky","year":"2013","unstructured":"Lukavsky, P. J. et al. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 20, 1443\u20131449 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"513_CR37","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1242\/jcs.038950","volume":"121","author":"YM Ayala","year":"2008","unstructured":"Ayala, Y. M. et al. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121, 3778\u20133785 (2008).","journal-title":"J. Cell Sci."},{"key":"513_CR38","doi-asserted-by":"publisher","first-page":"eaaf4382","DOI":"10.1126\/science.aaf4382","volume":"357","author":"Y Shin","year":"2017","unstructured":"Shin, Y. & Brangwynne, C. P. Liquid phase condensation in cell physiology and disease. Science 357, eaaf4382 (2017).","journal-title":"Science"},{"key":"513_CR39","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1126\/science.aar7366","volume":"360","author":"S Maharana","year":"2018","unstructured":"Maharana, S. et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science 360, 918\u2013921 (2018).","journal-title":"Science"},{"key":"513_CR40","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan, J. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668\u20131672 (2008).","journal-title":"Science"},{"key":"513_CR41","doi-asserted-by":"publisher","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","volume":"284","author":"BS Johnson","year":"2009","unstructured":"Johnson, B. S. et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329\u201320339 (2009).","journal-title":"J. Biol. Chem."},{"key":"513_CR42","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/hmg\/ddp275","volume":"18","author":"T Nonaka","year":"2009","unstructured":"Nonaka, T., Kametani, F., Arai, T., Akiyama, H. & Hasegawa, M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 18, 3353\u20133364 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"513_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nsmb.2053","volume":"18","author":"W Guo","year":"2011","unstructured":"Guo, W. et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol. 18, 822\u2013830 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"513_CR44","doi-asserted-by":"publisher","first-page":"e103644","DOI":"10.1371\/journal.pone.0103644","volume":"9","author":"CS Sun","year":"2014","unstructured":"Sun, C. S. et al. The influence of pathological mutations and proline substitutions in TDP-43 glycine-rich peptides on its amyloid properties and cellular toxicity. PLoS ONE 9, e103644 (2014).","journal-title":"PLoS ONE"},{"key":"513_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/emboj.2010.310","volume":"30","author":"YM Ayala","year":"2011","unstructured":"Ayala, Y. M. et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 30, 277\u2013288 (2011).","journal-title":"EMBO J."},{"key":"513_CR46","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1128\/MCB.01279-10","volume":"31","author":"CM Dewey","year":"2011","unstructured":"Dewey, C. M. et al. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell Biol. 31, 1098\u20131108 (2011).","journal-title":"Mol. Cell Biol."},{"key":"513_CR47","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1471-4159.2009.06383.x","volume":"111","author":"C Colombrita","year":"2009","unstructured":"Colombrita, C. et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 111, 1051\u20131061 (2009).","journal-title":"J. Neurochem."},{"key":"513_CR48","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nchembio.1563","volume":"10","author":"SJ Barmada","year":"2014","unstructured":"Barmada, S. J. et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 10, 677\u2013685 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"513_CR49","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/hmg\/ddr021","volume":"20","author":"KK McDonald","year":"2011","unstructured":"McDonald, K. K. et al. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 20, 1400\u20131410 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"513_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/hmg\/ddt408","volume":"23","author":"M Udan-Johns","year":"2014","unstructured":"Udan-Johns, M. et al. Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40\/70 chaperones. Hum. Mol. Genet. 23, 157\u2013170 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"513_CR51","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20140214","volume":"211","author":"ME Ward","year":"2014","unstructured":"Ward, M. E. et al. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J. Exp. Med. 211, 1937\u20131945 (2014).","journal-title":"J. Exp. Med."},{"key":"513_CR52","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/brain\/awq111","volume":"133","author":"AL Nishimura","year":"2010","unstructured":"Nishimura, A. L. et al. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain 133, 1763\u20131771 (2010).","journal-title":"Brain"},{"key":"513_CR53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","volume":"21","author":"CC Chou","year":"2018","unstructured":"Chou, C. C. et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD. Nat. Neurosci. 21, 228\u2013239 (2018).","journal-title":"Nat. Neurosci."},{"key":"513_CR54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.neuron.2019.02.038","volume":"102","author":"F Gasset-Rosa","year":"2019","unstructured":"Gasset-Rosa, F. et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339\u2013357 e7 (2019).","journal-title":"Neuron"},{"key":"513_CR55","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.febslet.2008.05.024","volume":"582","author":"MJ Winton","year":"2008","unstructured":"Winton, M. J. et al. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro. FEBS Lett. 582, 2252\u20132256 (2008).","journal-title":"FEBS Lett."},{"key":"513_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nbd.2014.12.010","volume":"75","author":"R Mutihac","year":"2015","unstructured":"Mutihac, R. et al. TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca(2)(+) signaling in motor neurons. Neurobiol. Dis. 75, 64\u201377 (2015).","journal-title":"Neurobiol. Dis."},{"key":"513_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ensci.2018.04.001","volume":"11","author":"S Mitsuzawa","year":"2018","unstructured":"Mitsuzawa, S. et al. TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43. eNeurologicalSci 11, 20\u201322 (2018).","journal-title":"eNeurologicalSci"},{"key":"513_CR58","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1523\/JNEUROSCI.2350-13.2014","volume":"34","author":"L Liu-Yesucevitz","year":"2014","unstructured":"Liu-Yesucevitz, L. et al. ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J. Neurosci. 34, 4167\u20134174 (2014).","journal-title":"J. Neurosci."},{"key":"513_CR59","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1093\/nar\/gki897","volume":"33","author":"PA Mercado","year":"2005","unstructured":"Mercado, P. A., Ayala, Y. M., Romano, M., Buratti, E. & Baralle, F. E. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res. 33, 6000\u20136010 (2005).","journal-title":"Nucleic Acids Res."},{"key":"513_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fnmol.2017.00170","volume":"10","author":"M Budini","year":"2017","unstructured":"Budini, M., Buratti, E., Morselli, E. & Criollo, A. Autophagy and its impact on neurodegenerative diseases: new roles for TDP-43 and C9orf72. Front. Mol. Neurosci. 10, 170 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"513_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40478-018-0531-3","volume":"6","author":"S Nag","year":"2018","unstructured":"Nag, S. et al. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer\u2019s disease. Acta Neuropathol. Commun. 6, 33 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"513_CR62","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3233\/JAD-180169","volume":"64","author":"A Sahoo","year":"2018","unstructured":"Sahoo, A. et al. TDP-43 and Alzheimer\u2019s disease pathologic subtype in non-amnestic Alzheimer\u2019s disease dementia. J. Alzheimers Dis. 64, 1227\u20131233 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"513_CR63","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs, K. A. et al. Staging TDP-43 pathology in Alzheimer\u2019s disease. Acta Neuropathol. 127, 441\u2013450 (2014).","journal-title":"Acta Neuropathol."},{"key":"513_CR64","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.21154","volume":"61","author":"C Amador-Ortiz","year":"2007","unstructured":"Amador-Ortiz, C. et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease. Ann. Neurol. 61, 435\u2013445 (2007).","journal-title":"Ann. Neurol."},{"key":"513_CR65","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","volume":"67","author":"K Uryu","year":"2008","unstructured":"Uryu, K. et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J. Neuropathol. Exp. Neurol. 67, 555\u2013564 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"513_CR66","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs, K. A. et al. TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease. Acta Neuropathol. 127, 811\u2013824 (2014).","journal-title":"Acta Neuropathol."},{"key":"513_CR67","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1212\/WNL.0000000000003610","volume":"88","author":"S Nag","year":"2017","unstructured":"Nag, S. et al. TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology 88, 653\u2013660 (2017).","journal-title":"Neurology"},{"key":"513_CR68","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.neuron.2009.12.016","volume":"64","author":"A Aguzzi","year":"2009","unstructured":"Aguzzi, A. & Rajendran, L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64, 783\u2013790 (2009).","journal-title":"Neuron"},{"key":"513_CR69","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrneurol.2010.145","volume":"6","author":"SJ Lee","year":"2010","unstructured":"Lee, S. J., Desplats, P., Sigurdson, C., Tsigelny, I. & Masliah, E. Cell-to-cell transmission of non-prion protein aggregates. Nat. Rev. Neurol. 6, 702\u2013706 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"513_CR70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45\u201351 (2013).","journal-title":"Nature"},{"key":"513_CR71","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fnagi.2019.00376","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Chen, Y., Liu, M., Wang, Y. & Peng, G. TDP-43 and limbic-predominant age-related TDP-43 encephalopathy. Front. Aging Neurosci. 11, 376 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"513_CR72","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2353\/ajpath.2007.070182","volume":"171","author":"NJ Cairns","year":"2007","unstructured":"Cairns, N. J. et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 171, 227\u2013240 (2007).","journal-title":"Am. J. Pathol."},{"key":"513_CR73","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl, C. C. et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 79, 1186\u20131189 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"513_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/archneurol.2008.558","volume":"66","author":"F Geser","year":"2009","unstructured":"Geser, F. et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch. Neurol. 66, 180\u2013189 (2009).","journal-title":"Arch. Neurol."},{"key":"513_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie, I. R. et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 122, 111\u2013113 (2011).","journal-title":"Acta Neuropathol."},{"key":"513_CR76","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","volume":"58","author":"GM McKhann","year":"2001","unstructured":"McKhann, G. M. et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick\u2019s Disease. Arch. Neurol. 58, 1803\u20131809 (2001).","journal-title":"Arch. Neurol."},{"key":"513_CR77","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1212\/WNL.0b013e3181e04070","volume":"74","author":"E Mioshi","year":"2010","unstructured":"Mioshi, E., Hsieh, S., Savage, S., Hornberger, M. & Hodges, J. R. Clinical staging and disease progression in frontotemporal dementia. Neurology 74, 1591\u20131597 (2010).","journal-title":"Neurology"},{"key":"513_CR78","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie, I. R. et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427\u2013434 (2007).","journal-title":"Ann. Neurol."},{"key":"513_CR79","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1212\/01.wnl.0000261045.57095.56","volume":"68","author":"J Ravits","year":"2007","unstructured":"Ravits, J., Laurie, P., Fan, Y. & Moore, D. H. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 68, 1576\u20131582 (2007).","journal-title":"Neurology"},{"key":"513_CR80","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","volume":"73","author":"JM Ravits","year":"2009","unstructured":"Ravits, J. M. & La Spada, A. R. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73, 805\u2013811 (2009).","journal-title":"Neurology"},{"key":"513_CR81","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","volume":"10","author":"B Swinnen","year":"2014","unstructured":"Swinnen, B. & Robberecht, W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 10, 661\u2013670 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"513_CR82","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2013.221","volume":"9","author":"H Braak","year":"2013","unstructured":"Braak, H. et al. Amyotrophic lateral sclerosis\u2014a model of corticofugal axonal spread. Nat. Rev. Neurol. 9, 708\u2013714 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"513_CR83","doi-asserted-by":"publisher","first-page":"e10627","DOI":"10.1371\/journal.pone.0010627","volume":"5","author":"R Chia","year":"2010","unstructured":"Chia, R. et al. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS ONE 5, e10627 (2010).","journal-title":"PLoS ONE"},{"key":"513_CR84","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1083\/jcb.201504057","volume":"211","author":"MS Feiler","year":"2015","unstructured":"Feiler, M. S. et al. TDP-43 is intercellularly transmitted across axon terminals. J. Cell Biol. 211, 897\u2013911 (2015).","journal-title":"J. Cell Biol."},{"key":"513_CR85","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka, T. et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 4, 124\u2013134 (2013).","journal-title":"Cell Rep."},{"key":"513_CR86","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.nbd.2016.08.007","volume":"96","author":"P Smethurst","year":"2016","unstructured":"Smethurst, P. et al. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol. Dis. 96, 236\u2013247 (2016).","journal-title":"Neurobiol. Dis."},{"key":"513_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/srep22155","volume":"6","author":"E Pokrishevsky","year":"2016","unstructured":"Pokrishevsky, E., Grad, L. I. & Cashman, N. R. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion. Sci. Rep. 6, 22155 (2016).","journal-title":"Sci. Rep."},{"key":"513_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00657-z","volume":"7","author":"S Peled","year":"2017","unstructured":"Peled, S. et al. Single cell imaging and quantification of TDP-43 and alpha-synuclein intercellular propagation. Sci. Rep. 7, 544 (2017).","journal-title":"Sci. Rep."},{"key":"513_CR89","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/19336896.2017.1314426","volume":"11","author":"R Zeineddine","year":"2017","unstructured":"Zeineddine, R. et al. Flow cytometric measurement of the cellular propagation of TDP-43 aggregation. Prion 11, 195\u2013204 (2017).","journal-title":"Prion"},{"key":"513_CR90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41593-018-0294-y","volume":"22","author":"F Laferriere","year":"2019","unstructured":"Laferriere, F. et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat. Neurosci. 22, 65\u201377 (2019).","journal-title":"Nat. Neurosci."},{"key":"513_CR91","doi-asserted-by":"publisher","first-page":"24178","DOI":"10.18632\/oncotarget.4680","volume":"6","author":"X Ding","year":"2015","unstructured":"Ding, X. et al. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget 6, 24178\u201324191 (2015).","journal-title":"Oncotarget"},{"key":"513_CR92","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi, Y. et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139, 3187\u20133201 (2016).","journal-title":"Brain"},{"key":"513_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06548-9","volume":"9","author":"S Porta","year":"2018","unstructured":"Porta, S. et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 9, 4220 (2018).","journal-title":"Nat. Commun."},{"key":"513_CR94","doi-asserted-by":"publisher","first-page":"9683","DOI":"10.1073\/pnas.0308413101","volume":"101","author":"B Fevrier","year":"2004","unstructured":"Fevrier, B. et al. Cells release prions in association with exosomes. Proc. Natl Acad. Sci. USA 101, 9683\u20139688 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"513_CR95","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran, L. et al. Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes. Proc. Natl Acad. Sci. USA 103, 11172\u201311177 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"513_CR96","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou, E. et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J. Neurosci. 30, 6838\u20136851 (2010).","journal-title":"J. Neurosci."},{"key":"513_CR97","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai, H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584\u20131593 (2015).","journal-title":"Nat. Neurosci."},{"key":"513_CR98","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ncb1841","volume":"11","author":"K Gousset","year":"2009","unstructured":"Gousset, K. et al. Prions hijack tunnelling nanotubes for intercellular spread. Nat. Cell Biol. 11, 328\u2013336 (2009).","journal-title":"Nat. Cell Biol."},{"key":"513_CR99","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-014-1299-6","volume":"128","author":"J Brettschneider","year":"2014","unstructured":"Brettschneider, J. et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 128, 423\u2013437 (2014).","journal-title":"Acta Neuropathol."},{"key":"513_CR100","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/jnen\/nlx025","volume":"76","author":"MD Cykowski","year":"2017","unstructured":"Cykowski, M. D. et al. Clinical significance of TDP-43 neuropathology in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 76, 402\u2013413 (2017).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"513_CR101","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/emboj.2013.122","volume":"32","author":"J Tong","year":"2013","unstructured":"Tong, J. et al. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 32, 1917\u20131926 (2013).","journal-title":"EMBO J."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00513-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T21:12:30Z","timestamp":1650229950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00513-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1038\/s12276-020-00513-7","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}